Immune effector cells – immunomodulatory network

The "Immune effector cells – immunomodulatory network" refers to the complex system of signaling pathways and cellular interactions that regulate the activity of immune cells such as T lymphocytes and Natural Killer (NK) cells (Abbas et al., 2021, Cellular and Molecular Immunology). This network maintains a delicate balance between immune activation and suppression through various checkpoint molecules, ensuring effective responses against pathogens while preventing autoimmunity (Pardoll, 2012, Nature Reviews Cancer). In the context of oncology, tumors often exploit this network by upregulating inhibitory signals, leading to a state of immune exhaustion and evasion (Chen & Mellman, 2013, Immunity). Therapeutic interventions, such as checkpoint inhibitors and CAR-T cell therapies, are designed to re-engage this network to enhance the body's anti-tumor response (June et al., 2018, Science). However, modulating these pathways can result in significant safety concerns, including immune-related adverse events (irAEs) and cytokine release syndrome (Postow et al., 2018, New England Journal of Medicine). Understanding the dynamics of this network is essential for the development of next-generation immunotherapies and personalized treatment strategies (Sharma & Allison, 2015, Science).

Other names

Immune checkpoint networkCancer-immunity cycleEffector cell signaling pathwaysImmunomodulatory signaling network

Modulation of inhibitory and stimulatory signaling pathways to regulate the activity and persistence of immune effector cells.